DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ifosfamide
Ifosfamide
VIP - Ifosfamide, Cisplatin and Etoposide
Hodgkin Lymphoma Treatment Regimens
Docetaxel, Ifosfamide and Cisplatin (DIP) in Squamous Cell Carcinoma of the Head and Neck
Arsenic Trioxide Is Highly Cytotoxic to Small Cell Lung Carcinoma Cells
Combination Chemotherapy with Estramustine Phosphate, Ifosfamide and Cisplatin for Hormone-Refractory Prostate Cancer
Prospective Randomized Clinical Trial Comparing High-Dose Ifosfamide + GM-CSF Vs High-Dose Cyclophosphamide + GM-CSF for Blood Progenitor Cell Mobilization
Systemic Therapy for Advanced Soft Tissue Sarcoma
Inp Doxorubicin Etoposide Ifosfamide Vincristine Videver1
Treatment and Prophylaxis of Ifosfamide-Induced Encephalopathy with Intravenous Methylene Blue
Ifosfamide and Etoposide-Based Chemotherapy As Salvage and Mobilizing Regimens for Poor Prognosis Lymphoma
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
Cancer Drug Costs for a Month of Treatment at Initial Food
Salvage Chemotherapy for Hormone-Refractory Prostate Cancer: Association of Adriamycin and Ifosfamide
Acronyms for Oncology Regimens
BC Cancer Protocol Summary for 3-Day Doxorubicin – Ifosfamide - Mesna for Use in Patients with Advanced Soft Tissue Sarcoma
No Additional Benefit of Adding Ifosfamide to Docetaxel in Castration-Resistant Metastatic Prostate Cancer
Inp Doxorubicinifosfamidever1
High-Dose Ifosfamide and Etoposide with Filgrastim for Stem Cell Mobilization in Patients with Advanced Ovarian Cancer
Top View
Chemotherapy Extravasation Management
BC Cancer Protocol Summary for Doxorubicin – Ifosfamide - Mesna for Use in Patients with Advanced Soft Tissue Sarcoma
Ifosfamide Richard J. Cardosi, MD, FACOG
Evolution of Nitrogen-Based Alkylating Anticancer Agents
Chapter 11. Chemotherapy and Kidney Injury
Ifosfamide in Combination with Paclitaxel Or Doxorubicin
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: a Retrospective Series
Proposal for the Inclusion of Mesna (Sodium 2-Mercaptoethane Sulfonate)
Emetogenic Potential of Antineoplastic Agents
Computationally Predicting Clinical Drug Combination Efficacy With
BC Cancer Protocol Summary for 3-Day Etoposide and Ifosfamide- Mesna for Patients with Advanced Soft Tissue Or Bony Sarcomas
IFEX (Ifosfamide for Injection, USP)
North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
Triplet Chemotherapy with Cisplatin, Ifosfamide and 5-Fluorouracil in Advanced Anal Cancer. a Population Based Retrospective An
Principles of Antineoplastic Therapy
GUVEIP Protocol
BC Cancer Protocol Summary for Etoposide, Ifosfamide-Mesna (SAIME) Alternating with Vincristine, Doxorubicin and Cyclophosphamid
Systemic High-Dose Methotrexate Plus Ifosfamide Is Highly Effective For
Sarcoma and Pnet
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Standard Oncology Criteria Policy Number: Pending
Ifosfamide/Etoposide Alternating with High-Dose Methotrexate (IEM) Related to Primary Treatment Details in Relapsed, Evaluable Patients
SOFT TISSUE SARCOMA TREATMENT REGIMENS (Part 1 of 2)
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 Day)
Download Master-Thesis
Clinical Activity of Arsenic Trioxide in Burkitt-Like Lymphoma 271
Inp-Cisplatin-Ifosfamide-Paclitaxel (TIP) Ver1.2
Oncology Rapid Pre-Hydration for Chemotherapy (Page 1 of 2)
Hazardous Drug List
CE SESHP Chemo Agents
TIP- Paclitaxel, Ifosfamide and Cisplatin Protocol V1.1
Paclitaxel-Ifosfamide-Cisplatin As Salvage Chemotherapy in Ovarian Cancer Patients Pretreated with Platinum Compounds and Paclitaxel
Doxorubicin & Ifosfamide Sarcoma Protocol
The Administration of Mesna with Ifosfamide and Cyclophosphamide Clinical Guideline
Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults
Enhanced Cyclophosphamide and Ifosfamide Activation in Primary